HEMORRHOID AND FISSURE- glycerin 6%,lidocaine 4%,ectoin 0.12% ointment
Hemorrhoid and Fissure by
Drug Labeling and Warnings
Hemorrhoid and Fissure by is a Otc medication manufactured, distributed, or labeled by FlexiGo Inc. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
- ACTIVE INGREDIENT
- DO NOT USE
- KEEP OUT OF REACH OF CHILDREN
- PURPOSE
- STOP USE
- DOSAGE & ADMINISTRATION
- WARNINGS
- INACTIVE INGREDIENT
- STORAGE AND HANDLING
- INDICATIONS & USAGE
- WHEN USING
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
HEMORRHOID AND FISSURE
glycerin 6%,lidocaine 4%,ectoin 0.12% ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC: 85524-2602 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ECTOIN (UNII: 7GXZ3858RY) (ECTOIN - UNII:7GXZ3858RY) ECTOIN 0.0012 g in 1 g LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE 0.04 g in 1 g GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 0.06 g in 1 g Inactive Ingredients Ingredient Name Strength GLYCERYL STEARATE (UNII: 230OU9XXE4) CHLORPHENESIN (UNII: I670DAL4SZ) PEG-100 STEARATE (UNII: YD01N1999R) TRIETHANOLAMINE (UNII: 9O3K93S3TK) METHYLPARABEN (UNII: A2I8C7HI9T) CI 16255 (UNII: Z525CBK9PG) ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS) POLYSORBATE 60 (UNII: CAL22UVI4M) PHENOXYETHANOL (UNII: HIE492ZZ3T) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) CI 19140 (UNII: I753WB2F1M) C13-14 ISOPARAFFIN (UNII: E4F12ROE70) LAURETH-7 (UNII: Z95S6G8201) WATER (UNII: 059QF0KO0R) ETHYLHEXYL PALMITATE (UNII: 2865993309) TREHALOSE (UNII: B8WCK70T7I) CARBOMER (UNII: 0A5MM307FC) PANTHENOL (UNII: WV9CM0O67Z) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SORBITAN STEARATE (UNII: NVZ4I0H58X) Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 85524-2602-2 1 in 1 BOX 01/19/2026 1 NDC: 85524-2602-1 42.5 g in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC: 85524-2602-4 1 in 1 BOX 01/19/2026 2 NDC: 85524-2602-3 42.5 g in 1 BOTTLE; Type 0: Not a Combination Product 3 NDC: 85524-2602-6 1 in 1 BOX 01/19/2026 3 NDC: 85524-2602-5 42.5 g in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M015 01/19/2026 Labeler - FlexiGo Inc (118951527) Establishment Name Address ID/FEI Business Operations FlexiGo Inc 118951527 label(85524-2602) , manufacture(85524-2602)
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.